comparemela.com

Latest Breaking News On - Boone capital management - Page 4 : comparemela.com

Investment House LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]

United-states
Illinois
Germany
Erick-rowinsky
America-bofa
Priya-singhal
Boone-capital-management
Illinois-municipal-retirement-fund
Securities-exchange-commission
Biogen-inc
A-global-asset-management-inc
Prudential-asset-management-co-ltd

Barclays Lowers Biogen (NASDAQ:BIIB) Price Target to $200.00

Barclays Lowers Biogen (NASDAQ:BIIB) Price Target to $200.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Illinois
United-states
Germany
Priya-singhal
Erick-rowinsky
Barclays
Dynamic-advisor-solutions
Illinois-municipal-retirement-fund
Prudential-asset-management-co-ltd
Canaccord-genuity-group
A-global-asset-management-inc
Biogen-inc

Bank Julius Baer & Co. Ltd Zurich Boosts Stake in Biogen Inc. (NASDAQ:BIIB)

Bank Julius Baer & Co. Ltd Zurich Boosts Stake in Biogen Inc. (NASDAQ:BIIB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Zurich
Züsz
Switzerland
Illinois
United-states
Germany
America
Priya-singhal
Erick-rowinsky
Dynamic-advisor-solutions
Illinois-municipal-retirement-fund
Biogen-inc

6,726 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Callan Capital LLC

Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […]

United-states
Yujiros-hata
Briseno-andres-ruiz
Leerink-partnrs
Werner-helicase
Nasdaq
Jpmorgan-chase-co
Eventide-asset-management
Barclays-plc
Biosciences-inc
Goldman-sachs-group
Walleye-capital

Biogen Inc. (NASDAQ:BIIB) to Post Q2 2024 Earnings of $3.43 Per Share, Wedbush Forecasts

Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Wedbush decreased their Q2 2024 earnings per share estimates for shares of Biogen in a report issued on Wednesday, April 24th. Wedbush analyst L. Chico now forecasts that the biotechnology company will post earnings per share of $3.43 for the quarter, down from their previous […]

United-states
Canada
Illinois
Germany
Priya-singhal
Erick-rowinsky
Nasdaq
Boone-capital-management
Royal-bank
Jpmorgan-chase-co
Prudential-asset-management-co-ltd
Illinois-municipal-retirement-fund

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.